Clinical Trials Browser

Phase 2/3 × Withdrawn × Neoplasm Metastasis × Clear all

NCT01861938 2025-10-02

Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients

Phase 2/3 Withdrawn

Melanoma, Neoplasm Metastasis